Spyre Therapeutics (SYRE) Shares Issued (2017 - 2026)

Spyre Therapeutics has reported Shares Issued for 10 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 1127.52% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 103.57% YoY), and the FY2025 full-year result was $3.3 million, down 55.98% from the prior year.
• Shares Issued for Q1 2026 stood at $2.7 million, down from $3.3 million in the prior quarter.
• The five-year high for Shares Issued was $169.2 million in Q1 2024, with the low at -$164.3 million in Q2 2024.
• Historically, Shares Issued has averaged $1.0 million across 5 years, with a median of $201000.0 in 2022.
• The largest YoY upside for Shares Issued was 939927.78% in 2024 against a maximum downside of 57312.41% in 2024.
• Spyre Therapeutics' Shares Issued stood at $38000.0 in 2022, then surged by 642.11% to $282000.0 in 2023, then sank by 57312.41% to -$161.3 million in 2024, then surged by 102.05% to $3.3 million in 2025, then retreated by 19.06% to $2.7 million in 2026.
• The last three Shares Issued figures came in at $2.7 million (Q1 2026), $3.3 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.